Key Points
- Itron CFO Joan Hooper sold 355 shares on May 20 at an average price of $79.60, for total proceeds of $28,258. The filing says the sale was to cover tax withholding tied to vesting equity awards, not a discretionary open-market sale.
- The stock recently traded near its 52-week low, opening at $81.85 versus a 1-year range of $77.77 to $142.00. Itron also sits below its 50-day and 200-day moving averages, suggesting weaker recent price momentum.
- Analysts remain mixed but generally constructive on Itron: Stephens reaffirmed an Overweight rating with a $130 target, while MarketBeat shows a consensus rating of Moderate Buy with an average price target of $131.22. However, Zacks Research recently cut several earnings estimates, pointing to some caution ahead.
Itron, Inc. (NASDAQ:ITRI - Get Free Report) SVP Laurie Ann Pulatie-Hahn sold 181 shares of Itron stock in a transaction that occurred on Wednesday, May 20th. The stock was sold at an average price of $79.60, for a total transaction of $14,407.60. Following the transaction, the senior vice president directly owned 32,469 shares in the company, valued at approximately $2,584,532.40. This represents a 0.55% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Laurie Ann Pulatie-Hahn also recently made the following trade(s):
- On Monday, May 11th, Laurie Ann Pulatie-Hahn sold 124 shares of Itron stock. The stock was sold at an average price of $81.59, for a total transaction of $10,117.16.
- On Friday, February 20th, Laurie Ann Pulatie-Hahn sold 729 shares of Itron stock. The stock was sold at an average price of $100.17, for a total transaction of $73,023.93.
Itron Price Performance
Itron stock opened at $81.85 on Friday. Itron, Inc. has a 52 week low of $77.77 and a 52 week high of $142.00. The company's 50 day moving average price is $88.63 and its two-hundred day moving average price is $94.60. The company has a quick ratio of 2.24, a current ratio of 2.66 and a debt-to-equity ratio of 0.97. The stock has a market cap of $3.63 billion, a P/E ratio of 13.05, a P/E/G ratio of 0.71 and a beta of 1.35.
Itron (NASDAQ:ITRI - Get Free Report) last posted its earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.26 by $0.23. Itron had a net margin of 12.31% and a return on equity of 19.54%. The firm had revenue of $586.98 million for the quarter, compared to analysts' expectations of $572.04 million. During the same quarter last year, the firm earned $1.52 EPS. The company's quarterly revenue was down 3.3% compared to the same quarter last year. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. On average, equities analysts predict that Itron, Inc. will post 6.01 earnings per share for the current year.
Itron News Roundup
Here are the key news stories impacting Itron this week:
- Positive Sentiment: Stephens reaffirmed its Overweight rating on Itron and kept a $130 price target, implying substantial upside from the current share price. Stephens reaffirms Overweight on Itron
- Neutral Sentiment: Several Itron executives sold small blocks of shares, but the filings say the transactions were mainly to cover tax withholding from equity award vesting, which makes the insider activity less concerning than open-market selling. SEC filing for insider sale
- Negative Sentiment: Zacks Research cut multiple earnings estimates for Itron, including a sharp reduction for Q4 2027 and a lower FY2027 forecast, signaling softer profit expectations ahead. Zacks Research estimate cuts for Itron
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. grew its stake in Itron by 2.3% in the 3rd quarter. Vanguard Group Inc. now owns 5,875,153 shares of the scientific and technical instruments company's stock valued at $731,809,000 after buying an additional 132,329 shares in the last quarter. Impax Asset Management Group plc boosted its holdings in Itron by 127.3% in the 3rd quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company's stock valued at $197,153,000 after purchasing an additional 890,040 shares during the period. Dimensional Fund Advisors LP boosted its holdings in Itron by 20.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,536,081 shares of the scientific and technical instruments company's stock valued at $137,659,000 after purchasing an additional 265,039 shares during the period. Geode Capital Management LLC boosted its holdings in Itron by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 1,144,982 shares of the scientific and technical instruments company's stock valued at $106,340,000 after purchasing an additional 6,598 shares during the period. Finally, Handelsbanken Fonder AB boosted its holdings in Itron by 6.0% in the 3rd quarter. Handelsbanken Fonder AB now owns 999,882 shares of the scientific and technical instruments company's stock valued at $124,545,000 after purchasing an additional 56,318 shares during the period. 96.19% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several research firms have commented on ITRI. Needham & Company LLC began coverage on shares of Itron in a research report on Friday, March 6th. They set a "buy" rating and a $124.00 target price on the stock. Raymond James Financial started coverage on shares of Itron in a research report on Tuesday, April 21st. They set an "underperform" rating on the stock. Zacks Research upgraded shares of Itron from a "strong sell" rating to a "hold" rating in a research note on Thursday, February 26th. JPMorgan Chase & Co. decreased their price target on shares of Itron from $133.00 to $113.00 and set an "overweight" rating for the company in a research note on Thursday, April 16th. Finally, Guggenheim set a $155.00 price target on shares of Itron in a research note on Friday, February 13th. Eight equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, Itron currently has an average rating of "Moderate Buy" and an average price target of $131.22.
Get Our Latest Stock Analysis on Itron
Itron Company Profile
(
Get Free Report)
Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company's offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.
Itron's product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
